Definitive Healthcare's CEO steps down, company reaffirms Q4 outlook

Definitive Healthcare ( NASDAQ: DH ) announced that Robert Musslewhite has stepped down as CEO and as a member of the Board to transition to a new phase of leadership for the company. Jason Krantz, Founder and Executive Chairman, has been appointed interim CEO. The Board has engaged a global executive search firm to commence a process to identify a permanent CEO.

The Company is also reaffirming its financial guidance for Q4 2023, as provided on November 3, 2023. The company expects FY 2024 revenue to grow 5% 7% compared to FY 2023 guidance while FY 2024 adjusted EBITDA margin is expected to increase about 200 basis points compared to FY 2023 guidance. Source: Press Release More on Definitive Healthcare Definitive Healthcare: Undervalued Vs.

Peers Given Revenue Growth And Margin Expansion Definitive Healthcare Corp. 2023 Q3 Results Earnings Call Presentation Definitive Healthcare Corp. (DH) Q3 2023 Earnings Call Transcript Definitive Healthcare stock dips after 154 job cuts in restructuring plan Seeking Alpha’s Quant Rating on Definitive Healthcare.